Insulin aspart, recombinant Subcutaneous and Omnaris eent
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Omnaris eent and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ciclesonide nasal
Brand name: Omnaris, Zetonna
Synonyms: Omnaris
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Omnicef
- Insulin aspart, recombinant Subcutaneous-Omnicef (Cefdinir Capsules)
- Insulin aspart, recombinant Subcutaneous-Omnicef (Cefdinir Suspension)
- Insulin aspart, recombinant Subcutaneous-Omnicef Omni-Pac
- Insulin aspart, recombinant Subcutaneous-Omnipaque
- Insulin aspart, recombinant Subcutaneous-Omnipaque 12
- Omnaris eent-Insulin degludec
- Omnaris eent-Insulin Degludec (U-100) Prefilled Pens
- Omnaris eent-Insulin Degludec (U-100) Vials
- Omnaris eent-Insulin Degludec (U-200) Prefilled Pens
- Omnaris eent-Insulin degludec and liraglutide
- Omnaris eent-Insulin degludec and liraglutide Subcutaneous